Abstract
Because of the recent and controversial example of sham surgery for the evaluation of fetal tissue transplants for Parkinson’s disease, there is renewed interest in the ethics of using “active” placebos in surgical trials, where otherwise there are no inert procedures available, and in pharmacological trials, where there are inert substances, but where patients may guess to which arm they have been allocated. This paper seeks to clarify the ethical arguments surrounding the use of active placebos in trials, and to set up a notation for assessing the ethics of trials more generally. We first establish an framework by which ethics committees can analyze such trials. We examine (1) the scientific value of the research; (2) the expected risks and benefits to individual patients, and (3) the voluntary nature of consent. We then contrast the implications of this framework for inert and active placebo-controlled trials, respectively. In particular, we analyze their relative expected utility using three main utility factors, namely, treatment effects, placebo effects, and altruism. We conclude that, when the intervention is already widely available, active placebo trials rely more heavily on altruism than do inert placebo trials and, when the intervention is restricted, this excess reliance may not be needed. What our analysis provides is the explicit justification for the apparent caution of Institutional Review Boards or ethics committees when reviewing sham operations, especially when the expected harm is not trivial and the risk of exploitation is high.
Similar content being viewed by others
References
S. Gottlieb (1999) ArticleTitleNews extra: Placebo surgery provokes controversy B.M.J. 319 942
AK Shapiro E Shapiro (1997) The Powerful Placebo The John Hopkins University Press Baltimore
TB Freeman DE Vawter PE Leaverton et al. (1999) ArticleTitleThe use of placebo surgery in controlled trials of celluar-based therapy for Parkinson’s disease N. Engl. J. Med. 341 988–992 Occurrence Handle10.1056/NEJM199909233411311 Occurrence Handle10498497
R. Macklin (1999) ArticleTitleThe ethical problems with sham surgery in clinical research N. Engl. J. Med. 341 992–996 Occurrence Handle10.1056/NEJM199909233411312 Occurrence Handle10498498
InstitutionalAuthorNameDepartment of Health, Human Services FaDA. (1998) ArticleTitleEstablishment registration and listing for manufacturers of human cellular and tissue-based products Fed. Regist. 63 26744–226755
Albin RL. Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed citeria for use of sham surgery controls. J. Med. Ethics 2002;28:322–325
JW Jones LB McCullough B W. Richman (2003) ArticleTitleThe ethics of sham surgery in research J. Vasc. Surg. 37 482–483 Occurrence Handle10.1067/mva.2003.112 Occurrence Handle12563228
S. French (1986) Decision Theory: An Introduction to the Mathematics of Rationality John Wiley and Sons New York
InstitutionalAuthorNameKant Immanuel (1991) Groundwork of the Metaphsyic of Morals Routledge London
O. O’Neill (1999) Autonomy and Trust in Bioethics Cambridge University Press Cambridge
KJ Rothman KB. Michels (1994) ArticleTitleThe continuing unethical use of placebo controls N. Engl. J. Med. 331 394–398 Occurrence Handle10.1056/NEJM199408113310611 Occurrence Handle8028622
Crow R, Gage H, Hampson S, et al. The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technol. Assess. 1999;3
E Gunnel H. Goran (1999) ArticleTitlePlacebo effect and randomised clinical trials Theoret. Medi. 16 171–182
A Hróbjartsson P. Gctzsche (2001) ArticleTitleIs the placebo powerless?—an analysis of clinical trials comparing placebo with no treatment N. Engl. J. Med. 344 1594–602 Occurrence Handle10.1056/NEJM200105243442106 Occurrence Handle11372012
SJL Edwards RJ Lilford J. Hewsion (1998) ArticleTitleThe ethics of RCTs from the perspective of patients, the public and health care of professionals B.M.J. 317 1209–1212
S Horng FG. Miller (2003) ArticleTitleEthical framework for the use of sham procedures in clinical trials Crit. Care Med. 31 IssueID3 Suppl S126–30 Occurrence Handle10.1097/01.CCM.0000054906.49187.67 Occurrence Handle12626957
DA Braunholtz SJL Edwards RJ Lilford et al. (2001) ArticleTitleClinical trials might be good for you: physical effects of participation J. Clin. Epidemiol. 54 000–000 Occurrence Handle10.1016/S0895-4356(00)00305-X
Weijer, I need a placebo like I need a hole in the head. J. Law Med. Ethics 30 (2002), pp.69–72
PA. Clark (2002) ArticleTitlePlacebo surgery for Parkinson’s disease: do the benefits outweigh the risks? J. Law Med. Ethics 30 58–68 Occurrence Handle11905269
O Tjomsland O Ekeberg K. Saatvedt (2001) ArticleTitlePlacebo effect in research related to surgery and technical procedures Tidsskr, Nor Laegeforen, 121 2290–2293
R. la Fuente-Fernandez Particlede (2004) ArticleTitleUncovering the hidden placebo effect in deep-brain stimulation for Parkinson’s disease Parkinsonism Relat. Disord. 10 125–127 Occurrence Handle10.1016/j.parkreldis.2003.10.003 Occurrence Handle15036165
F Benedetti L Colloca E Torre et al. (2004) ArticleTitlePlacebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus Nat. Neurosci. 7 587–588 Occurrence Handle10.1038/nn1250 Occurrence Handle15146189
R Tenery H Rakatansky FA Riddick SuffixJr et al. (2002) ArticleTitleSurgical “placebo” controls Ann. Surg. 235 303–307 Occurrence Handle10.1097/00000658-200202000-00021 Occurrence Handle11807373
AJ London JB. Kadane (2002) ArticleTitlePlacebos that harm: sham surgery controls in clinical trials Stat. Methods Med. Res. 11 413–427 Occurrence Handle10.1191/0962280202sm300ra Occurrence Handle12357587
SJL Edwards S Kirchin R. Huxtable (2004) ArticleTitleResearch ethics committees and paternalism J. Med. Ethics 30 88–91 Occurrence Handle10.1136/jme.2002.000166 Occurrence Handle14872083
U. Schuklenk (1998) Access to Experimental Drugs in Terminal Illness Pharmaceutical Products Press London
BP Minogue G Palmer-Fernandez L Udell et al. (1995) ArticleTitleIndividual autonomy and the double-blind controlled experiment: the case of desperate volunteers J. Med. Philos. 20 43–55 Occurrence Handle7738458
Edwards SJL, Restricting new treatments to trials. Bioethics forthcoming
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Edward, S.J.L., Stevens, A.J., Braunholtz, D.A. et al. The Ethics of Placebo-controlled Trials: A Comparison of Inert and Active Placebo Controls. World J. Surg. 29, 610–614 (2005). https://doi.org/10.1007/s00268-005-7621-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-005-7621-7